Advertisement vbandhakavi, Author at Pharmaceutical Business review - Page 11 of 155
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

All articles by vbandhakavi 

NovoMedix gets NIH grant to advance NMX1 in TNBC

Anthracyclines just as doxorubicin are the initial treatment of choice for TNBC. Although doxorubicin has reduced breast cancer mortality significantly, it is linked with a dose-dependent cumulative and

Procaps Group signs agreement to buy Grupo Somar

Grupo Somar is an integrated pharmaceutical company with focus on developing, manufacturing, and marketing branded generic, private label and OTC products aimed at the private market and providing